David R. McAvoy - Mar 4, 2024 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role
EVP, Chief Legal Officer
Signature
/s/ Dov Bergwerk as attorney-in-fact for David R. McAvoy
Stock symbol
TEVA
Transactions as of
Mar 4, 2024
Transactions value $
$0
Form type
4
Date filed
3/5/2024, 04:46 PM
Previous filing
Oct 4, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TEVA Restricted Share Units Award $0 +67 K $0.00 67 K Mar 4, 2024 Ordinary Shares 67 K Direct F1, F2, F3

Explanation of Responses:

Id Content
F1 Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
F2 Restricted share units were granted on March 4, 2024, with 16,741 vesting on each of March 4, 2025, March 4, 2026, March 4, 2027 and March 4, 2028.
F3 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.